Rao, read the 10Q and good to know every dollar raised from dilution has been judiciously spent for pre clinical trials, patents, INDs, IP.
400 percent increase in revenues compared to Dec 2019 qtr and it is going to go only up even before 500 people clinical trial has started.
Lots of things in pipeline with all its products making sales from now on. I would be looking for mention of TSOI products in the Peer Journal Review soon!
All in all everything looking good in TSOI s DIMELAND or should I say Silver Land!